دورية أكاديمية
أعرض في EDS

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

التفاصيل البيبلوغرافية
العنوان: Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
المؤلفون: Hu, YongxianAff1, Aff2, Aff3, Aff4, IDs4142202200721y_cor1, Zhou, YaliAff5, Aff6, Zhang, MingmingAff1, Aff2, Aff3, Aff4, Zhao, HouliAff1, Aff2, Aff3, Aff4, Wei, GuoqingAff1, Aff2, Aff3, Aff4, Ge, Wengang, Cui, Qu, Mu, Qitian, Chen, Gong, Han, Lu, Guo, Tingting, Cui, JiazhenAff1, Aff2, Aff3, Aff4, Jiang, Xiaoyan, Zheng, Xiujun, Yu, Shuhui, Li, Xiaolong, Zhang, Xingwang, Chen, Mingxi, Li, Xiuju, Gao, Ming, Wang, Kang, Zu, ChengAff1, Aff2, Aff3, Aff4, Zhang, Hao, He, Xiaohong, Wang, Yanbin, Wang, DongruiAff1, Aff2, Aff3, Aff4, IDs4142202200721y_cor26, Ren, JiangtaoAff5, IDs4142202200721y_cor27, Huang, HeAff1, Aff2, Aff3, Aff4, IDs4142202200721y_cor28
المصدر: Cell Research. 32(11):995-1007
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17487838
DOI:10.1038/s41422-022-00721-y